Src signaling in cancer invasion

M Guarino - Journal of cellular physiology, 2010 - Wiley Online Library
Src is a non‐receptor cytoplasmic tyrosine kinase which becomes activated following the
stimulation of plasma membrane receptors including receptor tyrosine kinases and integrins …

The transcription factor FOXM1 (Forkhead box M1): proliferation-specific expression, transcription factor function, target genes, mouse models, and normal biological …

I Wierstra - Advances in cancer research, 2013 - Elsevier
Abstract FOXM1 (Forkhead box M1) is a typical proliferation-associated transcription factor,
which stimulates cell proliferation and exhibits a proliferation-specific expression pattern …

Pathogenesis of lung cancer signalling pathways: roadmap for therapies

E Brambilla, A Gazdar - European Respiratory Journal, 2009 - Eur Respiratory Soc
Lung cancer is the major cancer killer worldwide, and 5-yr survival is extremely poor (≤
15%), accentuating the need for more effective therapeutic strategies. Significant advances …

The miR-18a* microRNA functions as a potential tumor suppressor by targeting on K-Ras

WP Tsang, TT Kwok - Carcinogenesis, 2009 - academic.oup.com
The Ras proto-oncogene mediates a wide variety of cellular events and is frequently
mutated in cancer. MicroRNAs (miRNAs) may regulate the development of cancer through …

RAS Mutations in Thyroid FNA Specimens Are Highly Predictive of Predominantly Low-Risk Follicular-Pattern Cancers

N Gupta, AK Dasyam, SE Carty… - The Journal of …, 2013 - academic.oup.com
Introduction: RAS mutations are common in thyroid tumors and confer a high risk of cancer
when detected in fine-needle aspiration (FNA) specimens. Specific characteristics of RAS …

Activating transcription factor 2 mediates matrix metalloproteinase-2 transcriptional activation induced by p38 in breast epithelial cells

H Song, SH Ki, SG Kim, A Moon - Cancer research, 2006 - AACR
Mounting evidence suggests a role for matrix metalloproteinase (MMP)-2 in the malignant
progression of breast cancer cells. We showed previously that H-Ras, but not N-Ras …

RAS mutations and oncogenesis: not all RAS mutations are created equally

MS Miller, LD Miller - Frontiers in genetics, 2012 - frontiersin.org
Mutation in RAS proteins is one of the most common genetic alterations observed in human
and experimentally induced rodent cancers. In vivo, oncogenic mutations have been shown …

Targeting receptor tyrosine kinase signalling in small cell lung cancer (SCLC): what have we learned so far?

B Fischer, M Marinov, A Arcaro - Cancer treatment reviews, 2007 - Elsevier
Small cell lung cancer (SCLC) is an aggressive form of lung cancer, which represents 13%
of all cases and is strongly associated with cigarette smoking. The survival of SCLC patients …

The role of miR-506 in transformed 16HBE cells induced by anti-benzo [a] pyrene-trans-7, 8-dihydrodiol-9, 10-epoxide

Y Zhao, H Liu, Y Li, J Wu, AR Greenlee, C Yang… - Toxicology letters, 2011 - Elsevier
Growing evidence indicates that the alteration of microRNA (miRNA) expression in tumors
that is induced by chemical carcinogens plays an important role in tumor development and …

[HTML][HTML] Role of RAS signaling in ovarian cancer

L Therachiyil, A Anand, A Azmi, A Bhat… - …, 2022 - ncbi.nlm.nih.gov
The RAS family of proteins is among the most frequently mutated genes in human
malignancies. In ovarian cancer (OC), the most lethal gynecological malignancy, RAS …